German Jordanian University Report issue

Academic/Hospital Phase 2

Organization Overview

First Clinical Trial
2009
NCT00900978
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2009

Timeline

NOW
  • Now

Alternative names

German-Jordanian University | German Jordanian University/ School of Applied Medical Sciences/ P.O.Box 35247 Amman/ 11180 Amman, Jordan

Active Ingredients

Drugs in Phase 2 Trials (1)

pneumococcal 13-valent conjugate vaccine (prevnar 13) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Pneumonia (Phase 2)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 1
  • # of Trial APIs: 1